The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

14 articles for S Basu


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine AEBI
Advinus Therapeutics
AEBI
Advinus Therapeutics
Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine AEBI
Advinus Therapeutics
Rational design, synthesis, and structure-activity relationships of 5-amino-1H-pyrazole-4-carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.EBI
Advinus Therapeutics
Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.EBI
Advinus Therapeutics
Revisiting glitazars: thiophene substituted oxazole containinga-ethoxy phenylpropanoic acid derivatives as highly potent PPARa/¿ dual agonists devoid of adverse effects in rodents.EBI
Zydus Research Centre
Discovery of a highly orally bioavailable c-5-[6-(4-Methanesulfonyloxyphenyl)hexyl]-2-methyl-1,3-dioxane-r-2-carboxylic acid as a potent hypoglycemic and hypolipidemic agent.EBI
Zydus Research Centre
Discovery of potent chromone-based autotaxin inhibitors inspired by cannabinoids.EBI
European Molecular Biology Laboratory
Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia.EBI
Advinus Therapeutics
The discovery of potent small molecule activators of human STING.EBI
Curadev Pharma
Design, Synthesis, Evaluation, and Structural Studies of EBI
Jagiellonian University
Discovery of Potent and Selective AEBI
Advinus Therapeutics
Design and synthesis of novel xanthine derivatives as potent and selective AEBI
Advinus Therapeutics
Compounds and compositions for treating conditions associated with cGASBDB
Novartis